Cancer Institute A national cancer institute
designated cancer center

Data and Safety Monitoring Committee (DSMC)

The DSMC is intended to oversee all aspects of data auditing, verify data validity and integrity, and ensure the safety of participants in all cancer clinical trials, including institutionally sponsored, investigator authored trials, and those trials without external monitoring that are active at Stanford University Cancer Institute. All cancer clinical trials require auditing commensurate with the degree of risk involved in the study subject participation, as well as the size and complexity of the study. The DSMC audits all investigator-initiated research, and reviews safety reports (grade 3 and above), and protocol deviations for all Stanford Cancer Institute studies.

Contact the DSMC


DSMC 2014 MEETING DATES
Mon
Jan 27
Noon FC180
Mon
Feb 24
Noon FC180
Mon
Mar 24
Noon FC180
Mon
Apr 28
Noon FC180
Mon
May 19
Noon FC180
Mon
Jun 23
Noon FC180
Mon
Jul 28
Noon FC180
Mon
Aug 25
Noon FC180
Mon
Sep 22
Noon FC180
Mon
Oct 27
Noon FC180
Mon
Nov 24
Noon FC180
Mon
Dec 15
Noon FC180

The DSMC ensures the safety of participants in all cancer clinical trials by reviewing grade 3 and above adverse events and protocol deviations. It is also responsible for data auditing to verify protocol compliance, data validity and integrity, for institutionally sponsored, investigator authored trials.

DSMC Resources

 

Stanford Medicine Resources:

Footer Links: